PWPS
MRTX

Pinnacle Wealth Planning Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-426
Closed -$94K – 2102
2020
Q4 		$94K Buy
+426
New +$92.1K 0.02% 500

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pinnacle Wealth Planning Services's MRTX Position: Q1 2021 in Review

Pinnacle Wealth Planning Services sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2021, closing a stake of 426 shares — an estimated $94K sold.

Pinnacle Wealth Planning Services first reported a position in MRTX in Q4 2020 and held it in 1 quarter. The position peaked at $94K in Q4 2020. 260 funds tracked by Wall St. Rank hold MRTX as of Q1 2021.

  • Pinnacle Wealth Planning Services reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 426 Mirati Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $94K.
  • Pinnacle Wealth Planning Services first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Pinnacle Wealth Planning Services's Mirati Therapeutics, Inc. Common Stock position peaked at $94K in Q4 2020.
  • 260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2021, filed 29 Apr 2021.